Examkin

Question

Difficulty: Very hardEnd-of-Life and Palliative Care

A 62-year-old man with metastatic prostate cancer is being evaluated in the palliative care clinic. He is currently experiencing poorly controlled bone pain and dose-limiting neurotoxicity, manifesting as myoclonus and hyperalgesia, on his high-dose oral morphine regimen. The physician decides to transition the patient to oral hydromorphone to improve pain control and resolve the neurotoxicity. Arrange the following steps of opioid rotation in the correct clinical sequence to safely and effectively transition the patient to the new regimen.

  1. 1Conduct a comprehensive clinical assessment to verify the indication for opioid rotation (e.g., dose-limiting toxicity).
  2. 2Calculate the total 2424-hour dose of the current opioid, incorporating both scheduled and as-needed doses used.
  3. 3Determine the equianalgesic 2424-hour dose of the new opioid using standardized pharmacological conversion tables.
  4. 4Reduce the calculated equianalgesic dose by 25%25\% to 50%50\% to adjust for incomplete cross-tolerance.
  5. 5Prescribe the adjusted dose at scheduled intervals alongside a proportional short-acting breakthrough dose.

Answer

The correct sequence is: Verify clinical indication, calculate total current 24-hour dose, convert to equianalgesic dose of new opioid, apply a 25-50% reduction for incomplete cross-tolerance, and finally prescribe the scheduled regimen with a proportional breakthrough dose.
The correct sequence for a safe opioid rotation begins with confirming the clinical indication. Next, the physician must calculate the exact 2424-hour consumption of the current opioid. This total is then converted to the equianalgesic dose of the target opioid using standardized tables. Crucially, this theoretical dose must then be reduced by 25%25\% to 50%50\% to account for incomplete cross-tolerance, protecting the patient from overdose. Finally, the safely adjusted dose is divided into a scheduled regimen, and a proportional PRN dose is added for breakthrough pain.

Step-by-Step Solution

1
Verify the clinical indication for rotation.
Confirmation that dose-limiting neurotoxicity necessitates changing the opioid agent.
Opioid rotation is indicated when dose escalation is precluded by severe side effects, ensuring the intervention is medically appropriate.
2
Calculate the current total daily opioid requirement.
Summation of all scheduled and PRN morphine doses taken over a 24-hour period.
Establishes an accurate baseline of opioid consumption prior to mathematical conversion.
3
Convert to the equianalgesic dose of the new opioid.
Calculation of the theoretical 24-hour hydromorphone requirement based on standard equivalence tables.
Provides a mathematically equivalent starting point for the new medication.
4
Apply a safety reduction for incomplete cross-tolerance.
The calculated equianalgesic dose is reduced by 25% to 50%.
Prevents fatal overdose, as patient opioid receptors are not fully cross-tolerant to structurally different opioid molecules.
5
Formulate and prescribe the final regimen.
The adjusted dose is divided into scheduled intervals, and a 10-15% breakthrough dose is provided.
Ensures continuous baseline analgesia with a safe, proportional rescue option for acute pain exacerbations.

Key Concept

Pharmacologic Interventions in Palliative Care: Opioid Rotation and Incomplete Cross-Tolerance
Rate this question

Topics

End-of-Life and Palliative Care

More questions from this topic